期刊文献+

人CD226(PTA1)分子胞膜外区的原核表达、复性及免疫反应性的鉴定 被引量:1

Prokaryotic expression and refolding renaturation of human CD226 (PTA1) and its immunological characterization
原文传递
导出
摘要 目的 构建人CD2 2 6 (PTA1)分子胞膜外区的原核表达载体 ,并进行原核表达和复性 ,为该分子的X线结晶衍射及功能学研究提供充足的蛋白来源。方法 将人CD2 2 6分子的胞膜外区基因克隆入原核表达载体pBV2 2 0 ,测序证实后 ,转化宿主菌MC10 6 1 P3并进行温度诱导表达。产物采用稀释加透析法复性 ,亲和层析柱纯化 ,并通过Westernblot和ELISA对其复性效果进行鉴定。结果 温度诱导 7h ,目的蛋白的表达量达宿主菌总蛋白量的 2 3.8% ,其相对分子质量为 30× 10 3,Westernblot及ELISA证实其重折叠和复性是成功的。结论 成功地获得了人CD2 2 6 (PTA1)分子胞膜外区的原核表达产物 。 Objective To construct the prokaryotic expression vector and express human CD226 (PTA1), in order to obtain CD226 recombinant molecules for X ray crystallographic analysis and functional study. Methods The gene fragment encoding extracellular region of human CD226 was cloned into a prokaryotic expression vector pBV220. After sequencing, the vector was transferred into MC1061/P3 and the expression of the molecule was induced. Finally, the product was renatured by dilution and dialysis, and then purified by affinity chromatography. The products were characterized by Western blot and ELISA. Relsults After 7 hours of temperature induction, the expressed protein with molecule weight of 30kD was amount to 23.8% of the total protein of the host cell. The refolding renaturation was successful confirmed by Western blot and ELISA. Conclusion The prokaryotic expression of the extracellular region of human CD226 is successful, which lays a foundation for the X ray crystallographic analysis and functional study of this molecule.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2002年第6期587-590,共4页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金重点项目(3 0 0 3 0 13 0 ) NationalKeyBasicResearchProgramofChina(20 0 1CB5 10 0 0 4) 面上项目(3 9980 0 0 6)
关键词 CD226 PTA1 胞膜外区 原核表达 免疫反应性 鉴定 重折叠复性 CD226 PTA1 Prokaryotic expression Refolding renaturation
  • 相关文献

参考文献4

二级参考文献19

  • 1宋礼华,王荣海,付永标,杨玲,杜贤宇,徐键.单克隆抗体亲和层析纯化人白细胞干扰素的研究[J].生命科学,1996,8(3):47-48. 被引量:2
  • 2Waine G J,Biochem Int,1992年,28卷,2期,255页
  • 3Quinlan K L,Immunology,1999年,162卷,1656页
  • 4Puri K D,Nature,1998年,392卷,6679期,930页
  • 5Tian F,The 10th International Congress of Immunol,1998年,349页
  • 6Sherrington P D,J Bio Chem,1997年,272卷,35期,21735页
  • 7Bussolino F,J Clin Invest,1991年,87卷,986页
  • 8Jin B Q,Immunol,1989年,66卷,570页
  • 9Scott J L,J Bio Chem,1989年,264卷,13475页
  • 10Sherrington P D,J Bio Chem,1997年,272卷,21735页

共引文献24

同被引文献10

  • 1金伯泉.人类白细胞分化抗原CD命名的最新进展[J].细胞与分子免疫学杂志,2005,21(2):131-132. 被引量:15
  • 2Meyaard L,Adema G J,Chang C et al.LAIR-1,a novel inhibitory receptor expressed on human monoclear leukocytes[J].Immunity,1997; 7(2):283-290.
  • 3Http://www.ncbi.nlm.nih.gov/prow/guide/1924844146_g.htm
  • 4Kistner A,Gossen M,Bujard H et al.Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice[J].Proc Natl Acad Sci USA,1996; 93:10933-10938.
  • 5Kai Schonig,Bujard H.Tetracycline-controlled gene expression[M].In:Hofker M H,Van Deursen J,eds.Methods in molecular biology.Totowa:Humana,2002:94-96.
  • 6Elke Ueberham,Rainer Low,Uwe Ueberham et al.Conditional tetracycline-regulated expression of TGF-β1 in liver of transgenic mice leads to reversible intermediary fibrosis[J].Hepatology,2003; 37(5):1067-1078.
  • 7Robert Jan Lebbink,Talitha De Ruiter,Meyaard L et al.The mouse homologue of the leukocyte-associated Ig-like receptor-1 is an inhibitory receptor that recruits src homology region 2-containing protein tyrosine phosphatase(SHP)-2,but not SHP-1[J].J Immunol,2004; 172(9):5535-5543.
  • 8Ryding A D S,Sharp M G F,Mullins J J.Conditional transgenic technologies[J].J Endocrinol,2001; 171:1-14.
  • 9Jochen Hess,Nielsen P J,Klaus-Dieter F et al.The B lymphocyte-specific Coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development[J].Mol Cell Biol,2001; 21(5):1531-1539.
  • 10Felsher D W,Bishop J M.Reversible tumorigenesis by MYC in Hematopoietic lineages[J].Mol Cell,1999; 4:199-207.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部